UNC-Chapel Hill researchers led by UNC Lineberger member Shawn Hingtgen, PhD, reach a critical milestone for treating brain cancer.
UNC Medical Center is First in the Mid Atlantic to Treat Patients with Next Generation Cardiac Mapping System
New technology enables tailored treatment for patients with cardiac arrhythmias.
With a whiff of the opposite sex, these hormone-sensitive neurons trigger pro-social behavior in mice and could play roles in anxiety, depression, and other mood-related conditions in humans.
As part of NIMH’s Experimental Therapeutics Initiative and led by Gabriel Dichter, PhD, researchers will use neuroimaging to evaluate a new treatment for decreased motivation and pleasure, symptoms that are common to many psychiatric disorders.
For the first time, UNC School of Medicine researchers crystalized the structure of LSD attached to a human serotonin receptor of a brain cell, and they may have discovered why an “acid trip” lasts so long.
A new NIH-funded consortium in North Carolina will offer Early Check, a free newborn screening done in partnership with the N.C. State Laboratory of Public Health, UNC, Duke University, and Wake Forest Baptist Medical Center.
UNC Lineberger researchers find how triple negative breast cancer cells are able to bypass treatment with trametinib, an FDA-approved drug. The researchers also used lab models of breast cancer to test a potential treatment approach that could prevent resistance.
UNC Lineberger researchers Ethan Basch, MD, MSc, and Stephanie Wheeler, PhD, MPH, called for tailored, local-level cancer prevention, screening and treatment efforts to address regional disparities in cancer mortality rates in an editorial published in JAMA on Tuesday.
Past winners include six scientists who went on to win the Nobel Prize.
UNC, NCSU biomedical engineering research team’s findings show that engineered platelets can deliver antibodies to kill cancer cells before they can grow or spread elsewhere in the body.
According to Anthony Charles, MD, MPH, of the UNC School of Medicine, the WHO should amend its centralization policy to help doctors save lives in Sub-Saharan Africa.
UNC's Dr. David Weber and Dr. William Rutala are co-authors of the study, which found that adding UV light to standard cleaning cut transmission of 4 resistant bacteria by 30 percent.
To ensure the safety of our patients, children ages 11 and younger are prohibited from visiting inpatient areas and waiting rooms at UNC Hospitals (at the Chapel Hill and Hillsborough locations) beginning Monday, Jan. 23, 2017.
This innovative model expands services available to patients.
Unmasking a previously misunderstood gene, University of North Carolina scientists discover an unlikely potential drug target for gastrointestinal cancers.
By focusing on small molecules called microRNAs in stem cells of the intestine, UNC School of Medicine researchers have proposed a new mechanism by which gut microbes might help keep us healthy or make us sick.
UNC clinical geneticists are part of a national consortium of researchers studying the ins and outs of genome sequencing for newborn health screenings and beyond.
New research led by scientists at the UNC School of Medicine and NC State University demonstrates the effectiveness of using prebiotics to change the composition of the gut microbiome of those suffering from lactose intolerance.
In a perspective published in the New England Journal of Medicine, Ethan Basch, MD, MSc, professor of medicine and director of UNC Lineberger’s Cancer Outcomes Research Program, addressed the need for – and the barriers preventing – electronic reporting of patients’ symptoms between visits.